Header Logo

Connection

Alan Landay to Fibroblast Growth Factor 7

Back to Details
This is a "connection" page, showing publications Alan Landay has written about Fibroblast Growth Factor 7.
Alan Landay
Connection Strength
0.120
Fibroblast Growth Factor 7
  1. A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy. J Acquir Immune Defic Syndr. 2014 Aug 01; 66(4):399-406.
    View in: PubMed
    Score: 0.120
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.